|
시장보고서
상품코드
2039081
질칸디다증 치료제 시장 : 약제 유형별, 투여 경로별, 유통 채널별, 지역별Vaginal Fungi Infections Treatment Market, By Drug Type, By Route of Administration, By Distribution Channel, By Geography |
||||||
질칸디다증 치료제 시장은 2026년에 13억 4,750만 달러로 추계되고 있으며, 2033년까지 19억 3,590만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 5.4%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 13억 4,750만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 5.40% | 2033년 시장 규모 예측 : | 19억 3,590만 달러 |
질 칸디다증은 질과 외음부(질 입구에 있는 조직)에 자극, 분비물, 심한 가려움증을 유발하는 진균 감염입니다. 질 칸디다증, 질 칸디다증, 외음부 질 칸디다증, 칸디다성 질염 또는 질 칸디다증이라고도 불리는 질 칸디다증은 미국 질병예방통제센터(CDC)에 따르면 미국에서 두 번째로 흔한 질 감염 질환입니다.
시장 역학
질 칸디다증 발생률의 증가가 질 칸디다증 치료제 시장의 성장을 주도하고 있습니다. 예를 들어 미국 질병예방통제센터(CDC)의 2018년 자료에 따르면 미국에서는 매년 약 140만 건의 질 칸디다증으로 인한 외래 진료가 이루어지고 있습니다. 또한 2020년 2월 Multidisciplinary Digital Publishing Institute(MDPI)에 발표된 논문에 따르면 외음부 질 칸디다증(VVC)은 인간의 칸디다 감염 중 가장 높은 유병률을 보이며, 전 세계 여성의 약 75%가 일생 동안 적어도 한 번은 적어도 한 번은 앓고 있습니다. 또한 전 세계 여성의 약 8%가 재발성 외음부 질 칸디다증(RVVC)을 앓고 있다고 합니다.
그러나 질 진균 감염증 치료의 대체요법이 시장 성장을 저해할 수 있습니다. 예를 들어 영양 보충제 및 퍼스널 케어 전문 기업 Nutrablast는 질 진균 감염증을 치료하기 위해 티트리 좌약을 제공하고 있습니다. 이 제품은 천연 티트리 오일을 사용하여 질내 환경의 균형을 맞추는 것을 목표로 합니다.
본 조사의 주요 특징
- 이 보고서는 다양한 부문의 잠재적 매출 창출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신약 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요 인사이트를 제공합니다.
- 이 보고서는 회사 개요, 재무 실적, 제품 포트폴리오, 시장 입지, 유통 전략, 주요 개발, 전략 및 향후 계획과 같은 매개 변수를 기반으로 세계의 질 칸디다증 치료제 시장의 주요 기업 개요을 작성합니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 의약품 출시, 약제 클래스 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 세계의 질 칸디다증 치료제 시장 보고서는 투자자, 공급업체, 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 글로벌 질 칸디다증 치료제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 범위
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 질칸디다증 치료제 시장 : 약제 유형별, 2021-2033년
제5장 세계의 질칸디다증 치료제 시장 : 투여 경로별, 2021-2033년
제6장 세계의 질칸디다증 치료제 시장 : 유통 채널별, 2021-2033년
제7장 세계의 질칸디다증 치료제 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 섹션
KSA 26.06.02Vaginal Fungi Infections Treatment Market is estimated to be valued at USD 1,347.5 Mn in 2026 and is expected to reach USD 1,935.9 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1,347.5 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.40% | 2033 Value Projection: | USD 1,935.9 Mn |
A vaginal yeast infection is a fungal infection that causes irritation, discharge, and intense itchiness of the vagina and the vulva - the tissues at the vaginal opening. Vaginal fungi infection is also known as vaginal yeast infection, vulvovaginal candidiasis, candidal vaginitis or vaginal candidiasis, and it the second most common type of vaginal infection in the U.S., according the Centers for Disease Control and Prevention.
Market Dynamics
Rising incidence of vaginal fungi infections are driving vaginal fungi infections treatment market growth. For instance, according to the Centers for Disease Control and Prevention (CDC), 2018, around 1.4 million outpatient visits occur for vaginal candidiasis every year in the U.S. Moreover, according to an article published in Multidisciplinary Digital Publishing Institute (MDPI) in February 2020, Vulvovaginal candidiasis (VVC) is the most prevalent human candidal infection and nearly 75% women across the globe are affected by it least once in their lifetime. Furthermore, according to the same source, around 8% women across the globe suffer from Recurrent Vulvovaginal Candidiasis (RVVC).
However, alternative therapies for vaginal fungi infections treatment can hinder the market growth. For instance, Nutrablast, a dedicated company in the dietary supplement and personal care offers Tea Tree Suppositories for vaginal fungi infections treatment. The product is natural tea tree oil to provide a balanced vaginal environment.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global Vaginal Fungi Infections Treatment Market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study are Pfizer Inc., Bausch Health Companies Inc, ANI Pharmaceuticals, Inc., Hikma Pharmaceuticals Plc, Lupin Limited, Mycovia Pharmaceuticals, Inc., Glenmark Pharmaceuticals Limited, Unique Pharmaceuticals, PEPTONIC medical AB, Aurobindo Pharma Limited, Dr. Reddy's Laboratories, and SCYNEXIS, Inc.
- Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
- The global Vaginal Fungi Infections Treatment Market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vaginal fungi infections treatment market.
Market Segmentation
- By Drug Type (Revenue, USD Mn, 2021-2033)
- Fluconazole
- Nystatin
- Flucytosine
- Others
- By Route of Administration (Revenue, USD Mn, 2021-2033)
- Oral
- Topical
- By Distribution Channel (Revenue, USD Mn, 2021-2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies.
- By Region (Revenue, USD Mn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Competitive Landscape
- Pfizer Inc.
- Bausch Health Companies Inc
- ANI Pharmaceuticals, Inc.
- Hikma Pharmaceuticals Plc
- Lupin Limited, Mycovia Pharmaceuticals, Inc.
- Glenmark Pharmaceuticals Limited
- Unique Pharmaceuticals
- PEPTONIC medical AB
- Aurobindo Pharma Limited
- Reddy's Laboratories
- SCYNEXIS, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Pipeline Analysis
- Reimbursement Scenario
- Epidemiology
- Pest Analysis
- Regulatory Scenario
- New Product Launches
- Collaborations and Agreements
- Market Trends
4. Global Vaginal Fungi Infections Treatment Market, By Drug Type, 2021- 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Fluconazole
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021- 2033, (US$ Mn)
- Nystatin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021- 2033, (US$ Mn)
- Flucytosine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021- 2033, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021- 2033, (US$ Mn)
5. Global Vaginal Fungi Infections Treatment Market, By Route of Administration, 2021- 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021- 2033, (US$ Mn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021- 2033, (US$ Mn)
6. Global Vaginal Fungi Infections Treatment Market, By Distribution Channel, 2021- 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021- 2033, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021- 2033, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021- 2033, (US$ Mn)
7. Global Vaginal Fungi Infections Treatment Market, By Region, 2021- 2033, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- North America
- Market Size and Forecast, By Drug Type, 2021- 2033, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2021- 2033, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2021- 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021- 2033, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Drug Type, 2021- 2033, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2021- 2033, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2021- 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021- 2033, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Drug Type, 2021- 2033, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2021- 2033, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2021- 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021- 2033, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Drug Type, 2021- 2033, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2021- 2033, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2021- 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021- 2033, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Drug Type, 2021- 2033, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2021- 2033, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2021- 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021- 2033, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Drug Type, 2021- 2033, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2021- 2033, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2021- 2033, (US$ Mn)
- Market Size and Forecast, By Country/Region, 2021- 2033, (US$ Mn)
- South Africa
- Central Africa
- North Africa
8. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bausch Health Companies Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- ANI Pharmaceuticals, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Hikma Pharmaceuticals Plc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Lupin Limited
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Mycovia Pharmaceuticals, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Glenmark Pharmaceuticals Limited
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Unique Pharmaceuticals
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- PEPTONIC medical AB
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Aurobindo Pharma Limited
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Reddy's Laboratories
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- SCYNEXIS, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Analyst Views
- Pfizer Inc.
9. Section
- References
- Research Methodology
- About us and Sales Contact
